TB-500 10mg
Thymosin β4 fragment · systemic repair, flexibility and antifibrosis
For research use only (RUO)
Ships from Quito · EC 1-3 days · LATAM 4-10
Arrives damaged? We replace it free
COA per batch4 mechanisms. One peptide.
What this peptide does at the cellular level, in plain words.
Systemic, multi-zone recovery
Works body-wide, not just at one spot: useful when several areas need to recover at once.
Mobilizes reparative cells
Regulates actin and mobilizes reparative cells toward damaged tissue, supporting cell migration.
Antifibrosis · repair quality
Supports more organized repair, with less scar tissue.
Inflammation & immune modulation
Helps modulate the inflammatory and immune response during recovery.
Stacks. What to pair it with.
Peptides often synergize. These are the most studied combinations with this product, and what outcome they target.
Any combination must respect each peptide's protocol. If you have doubts about dosing or timing, message us before starting.
Technical description.
TB-500 is the synthetic fragment of Thymosin Beta-4 (Tβ4), a protein found naturally in almost every human cell and tied to tissue repair. Its role is systemic: it regulates actin —the protein that orchestrates cell migration— and mobilizes reparative cells toward the damaged area. That is why it complements BPC-157, which repairs more locally: TB-500 works across several areas of the body at once.
SuperBio Labs TB-500 is supplied as lyophilized powder ≥99% pure, verified by HPLC and sequence-confirmed by LC-MS. Each batch ships with a third-party Certificate of Analysis covering identity, purity, peptide content, and endotoxin levels.
TB-500 research focuses on tissue repair, antifibrosis and inflammation modulation. Let's be honest about the level of evidence: by the injectable route the data are preclinical (animal models) — there are no clinical trials proving efficacy in humans by this route. Full-length Thymosin Beta-4 does have human data: as a gel it closed ulcers sooner in phase 2 (RGN-137), though not statistically significant and as eye drops it improved the cornea and dry eye (phase 3, RGN-259), although a 2025 European trial missed its endpoint. In models it also protects the heart after a heart attack. None of that equals proven injectable efficacy.
Safety. A tumor angiogenesis signal has been described: as a precaution, TB-500 is contraindicated in active cancer or with a prior cancer history. It is a controlled substance in sport (WADA S2). This is not medical advice; a product for research use only (RUO). If you have pre-existing medical conditions, consult a professional before using it.
Your complete kit, ready to apply.
We don't just hand you the vial. Every TB-500 purchase includes everything you need to apply it safely, with a clear protocol and our team available 24/7.
TB-500 vial
Lyophilized · HPLC purity ≥99% · Batch with COA
Bacteriostatic water 30ml
Sterile diluent · 0.9% benzyl alcohol
1 extraction syringe 3ml
21G needle · For peptide reconstitution
30 insulin syringes (29G)
30 units · daily · 30-day cap
31 alcohol wipes 70%
1 per application + 1 to reconstitute
Your protocol and product sheet, in the app
Free app · Week-by-week protocol, product sheet and usage guide
Visual step-by-step guide
8 steps · From opening the kit to application
SuperBio OS · Support
App · Tracking · Human team 24/7
About supplies: the quantity of syringes and wipes adjusts automatically based on the presentation you choose. For extended cycles (BPC-157, GHK-Cu and similar) we cap supplies at 30 days — beyond that, 29G insulin syringes and 70% alcohol wipes are pharmacy items available without prescription in any city.
How to choose where to buy peptides.
This product meets all five — your batch COA ships with the kit.
Recommended application protocol.
The official protocol included in the kit. If you have pre-existing medical conditions, consult a professional before starting.
Recommended titration
No ramp-up: 1 mg from week 1 through 8.
Combine with BPC-157 for complete recovery: TB-500 mobilizes systemically, BPC-157 repairs at the injury site.
When to use TB-500.
Injuries in several areas
Systemic action: no need to apply it nearby · complements BPC-157, which is more local.
Muscle tear
Muscle fiber and fascia · loading 2×/week, then maintenance.
Stiffness and scarring
Scar tissue and adhesions · antifibrotic effect in animal models.
Post-surgery
With BPC-157 in Wolverine to cover local and systemic repair.
Background inflammation
Cytokine modulation in animal models · background support during recovery.
Hair
Hair follicle via Tβ4 · preclinical signal, not a first choice.
Wounds that will not close
Ulcers and slow wounds: thymosin β4 gel closed them sooner in phase 2, not significant (full-protein data).
Honest side effects.
Well tolerated in animal models. Human data come from full-length thymosin β4 (topical and ocular); TB-500 itself has no published clinical trials.
Most reported: tiredness or drowsiness in the first days · heavy head · redness at the application site. It promotes cell migration and vessel formation: it is not used with active or recent cancer. Pregnancy and breastfeeding: no data. For athletes: thymosin β4 and its derivatives are on the WADA list (S2).
Technical specifications
| CAS number | 885340-08-9 |
| Molecular weight | ≈889 Da |
| Purity (HPLC) | ≥99% |
| Format | Lyophilized powder |
| Quantity | 10 mg per vial |
| Endotoxins | <1.0 EU/mg |
| Storage | −20 °C, protected from light |
| Use | Use under professional judgment |